PDCD1 and neoplasm: Based on the data, more anti-PD-1 drug was detected in CU06-1004 treated group than that of control group and anti-PD-1 antibody implied that vessel normalization by CU06-1004 treatment induces increased trafficking of drug to the lymphocyte within the tumor site.